Skip to main content Back to Top
Advertisement

4/16/2020

Yellow Fever Vaccine

Products Affected - Description

    • YF-Vax subcutaneous powder for suspension for injection, Sanofi Pasteur, Multiple-dose vial (5 doses per vial) with diluent 1 count, NDC 49281-0915-05
    • YF-Vax subcutaneous powder for suspension for injection, Sanofi Pasteur, Single-dose vial with diluent, 5 count, NDC 49281-0915-01

Reason for the Shortage

    • Sanofi Pasteur states the shortage of YF-Vax is due to production delays. [1]
    • There are no other suppliers of yellow fever vaccine.
    • Additional information on the yellow fever shortage is available at https://wwwnc.cdc.gov/travel/news-announcements/yellow-fever-vaccine-access.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Sanofi Pasteur has YF-Vax multi-dose vials and single dose vials on back order and the company cannot estimate a release date.[1]
    • Sanofi Pasteur has worked with FDA to make another vaccine, Stamaril, available in the US under an investigational new drug program. Stamaril is yellow fever vaccine manufactured by Sanofi Pasteur in France. It is not licensed in the US. Under the program, Stamaril is supplied to a limited number of clinics. Clinics providing access to Stamaril can be found at https://wwwnc.cdc.gov/travel/page/search-for-stamaril-clinics. More information can be found at https://www.cdc.gov/mmwr/volumes/66/wr/mm6617e2.htm?s_cid=mm6617e2_w or at https://www.vaccineshoppe.com/index.cfm?fa=anon.content&n=YellowFever&title=.
    • Stamaril is on allocation due to supply demand.[1]

Implications for Patient Care

    • Yellow fever vaccine must be used within 1 hour of reconstitution. Practitioners should consider scheduling several patients for immunization simultaneously to conserve use of YF-Vax 5-dose vials.[2]

Alternative Agents & Management

    • Information on countries that require yellow fever vaccination can be found at https://wwwnc.cdc.gov/travel/.

References

    1. Sanofi Pasteur, Customer Service (personal communication and website). November 24 and December 15, 2015; January 13, February 3, March 22, April 18, May 31, July 20, September 27, and November 29, 2016; January 31, March 27, June 27, August 29, November 1, December 15, 2017; February 7, April 11, June 11, August 1, October 25, 2018; and January 30, April 15 and 26, July 9, October 9, November 11, December 18, 2019; January 14 and April 16, 2020.
    2. Yellow Fever Vaccine (YF-Vax). Product information. Swiftwater, PA: Sanofi Pasteur, 2014 March.

Updated

Updated April 16, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 24, 2015 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.